Category: Medications - Page 2
When Sticking to Brand Name Medications Makes a Difference: Rare Cases Where It Matters
While generics save money, rare cases exist where sticking with brand-name medications improves patient outcomes through psychological trust, neurological consistency, and stable absorption. Learn when it matters.
- December 16 2025
- Tony Newman
- 12 Comments
European Generic Markets: Regulatory Approaches Across the EU in 2025
In 2025, new EU regulations are transforming how generic drugs enter the market. Learn how the Pharma Package changes approval paths, data protection, and supply rules-and what it means for manufacturers and patients.
- December 15 2025
- Tony Newman
- 13 Comments
Cyclosporine Nephrotoxicity: How to Monitor Kidney Function and Drug Levels Safely
Cyclosporine saves transplant lives but can damage kidneys if not carefully monitored. Learn how to track blood levels, kidney function, and avoid dangerous drug interactions to protect your transplant.
- December 14 2025
- Tony Newman
- 15 Comments
Cost Sharing Explained: Deductibles, Copays, and Coinsurance for Medication Costs
Understand how deductibles, copays, and coinsurance affect your medication costs. Learn how these out-of-pocket expenses work, how they add up, and how to save money on prescriptions.
- December 12 2025
- Tony Newman
- 15 Comments
OTC Diarrhea Treatments: When to Use and When to See a Doctor
Learn when to use OTC diarrhea treatments like Imodium and Pepto-Bismol - and when to skip them and see a doctor. Avoid dangerous mistakes and know the real signs you need medical help.
- December 11 2025
- Tony Newman
- 15 Comments
Planning for Patent Expiry: What Patients and Healthcare Systems Need to Do Now
Patent expirations are triggering massive drug price drops-but most patients and health systems aren’t ready. Learn what you need to do now to avoid disruptions, save money, and stay safe.
- December 7 2025
- Tony Newman
- 9 Comments
Anticoagulant Reversal Agents: Idarucizumab, Andexanet Alfa, PCC, and Vitamin K Explained
Learn how idarucizumab, andexanet alfa, PCC, and vitamin K reverse blood thinners in emergencies. Compare speed, safety, cost, and real-world use for warfarin and DOACs.
- December 6 2025
- Tony Newman
- 13 Comments
Amiodarone, Digoxin, and Warfarin: The Dangerous Drug Triad You Can't Ignore
Amiodarone, digoxin, and warfarin together create a deadly drug interaction that can cause toxic digoxin levels and life-threatening bleeding. Learn how to spot the signs, adjust doses safely, and protect yourself or a loved one.
- December 4 2025
- Tony Newman
- 8 Comments
Active vs Inactive Drug Ingredients: Why the Difference Matters for Your Health
Active ingredients treat your condition, but inactive ingredients can cause side effects, trigger allergies, or even affect how well your medicine works. Know what’s really in your pills.
- November 28 2025
- Tony Newman
- 15 Comments
Bioequivalence Studies: What the FDA Requires Generic Drug Manufacturers to Prove
The FDA requires generic drug manufacturers to prove bioequivalence through rigorous studies showing their product absorbs at the same rate and extent as the brand-name drug. Learn the 80/125 rule, biowaivers, NTID exceptions, and why this matters for patient safety.
- November 27 2025
- Tony Newman
- 12 Comments